BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 24756222)

  • 21. Fibroblast-derived CXCL12 regulates PTEN expression and is associated with the proliferation and invasion of colon cancer cells via PI3k/Akt signaling.
    Ma J; Sun X; Wang Y; Chen B; Qian L; Wang Y
    Cell Commun Signal; 2019 Sep; 17(1):119. PubMed ID: 31500630
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of Sulindac and Celecoxib in the regulation of angiogenesis during the early neoplasm of colon: exploring PI3-K/PTEN/Akt pathway to the canonical Wnt/β-catenin signaling.
    Vaish V; Sanyal SN
    Biomed Pharmacother; 2012 Jul; 66(5):354-67. PubMed ID: 22397759
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Resveratrol suppresses IGF-1 induced human colon cancer cell proliferation and elevates apoptosis via suppression of IGF-1R/Wnt and activation of p53 signaling pathways.
    Vanamala J; Reddivari L; Radhakrishnan S; Tarver C
    BMC Cancer; 2010 May; 10():238. PubMed ID: 20504360
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ALDH1B1 Is Crucial for Colon Tumorigenesis by Modulating Wnt/β-Catenin, Notch and PI3K/Akt Signaling Pathways.
    Singh S; Arcaroli J; Chen Y; Thompson DC; Messersmith W; Jimeno A; Vasiliou V
    PLoS One; 2015; 10(5):e0121648. PubMed ID: 25950950
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methylated urolithin A, the modified ellagitannin-derived metabolite, suppresses cell viability of DU145 human prostate cancer cells via targeting miR-21.
    Zhou B; Wang J; Zheng G; Qiu Z
    Food Chem Toxicol; 2016 Nov; 97():375-384. PubMed ID: 27725205
    [TBL] [Abstract][Full Text] [Related]  

  • 26. E-cadherin inhibits tumor cell growth by suppressing PI3K/Akt signaling via β-catenin-Egr1-mediated PTEN expression.
    Lau MT; Klausen C; Leung PC
    Oncogene; 2011 Jun; 30(24):2753-66. PubMed ID: 21297666
    [TBL] [Abstract][Full Text] [Related]  

  • 27. F-box and leucine-rich repeat protein 5 promotes colon cancer progression by modulating PTEN/PI3K/AKT signaling pathway.
    Yao H; Su S; Xia D; Wang M; Li Z; Chen W; Ren L; Xu L
    Biomed Pharmacother; 2018 Nov; 107():1712-1719. PubMed ID: 30257389
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SPAG6 silencing induces apoptosis in the myelodysplastic syndrome cell line SKM‑1 via the PTEN/PI3K/AKT signaling pathway in vitro and in vivo.
    Yin J; Li X; Zhang Z; Luo X; Wang L; Liu L
    Int J Oncol; 2018 Jul; 53(1):297-306. PubMed ID: 29749435
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oridonin upregulates PTEN through activating p38 MAPK and inhibits proliferation in human colon cancer cells.
    Wu QX; Yuan SX; Ren CM; Yu Y; Sun WJ; He BC; Wu K
    Oncol Rep; 2016 Jun; 35(6):3341-8. PubMed ID: 27108927
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ursolic acid inhibits proliferation and induces apoptosis by inactivating Wnt/β-catenin signaling in human osteosarcoma cells.
    Zhang RX; Li Y; Tian DD; Liu Y; Nian W; Zou X; Chen QZ; Zhou LY; Deng ZL; He BC
    Int J Oncol; 2016 Nov; 49(5):1973-1982. PubMed ID: 27665868
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oridonin inhibits the proliferation of human osteosarcoma cells by suppressing Wnt/β-catenin signaling.
    Liu Y; Liu YZ; Zhang RX; Wang X; Meng ZJ; Huang J; Wu K; Luo JY; Zuo GW; Chen L; Yin LJ; Deng ZL; He BC
    Int J Oncol; 2014 Aug; 45(2):795-803. PubMed ID: 24859848
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel ent-kaurane diterpenoid executes antitumor function in colorectal cancer cells by inhibiting Wnt/β-catenin signaling.
    Ye Q; Yao G; Zhang M; Guo G; Hu Y; Jiang J; Cheng L; Shi J; Li H; Zhang Y; Liu H
    Carcinogenesis; 2015 Mar; 36(3):318-26. PubMed ID: 25600769
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of IGFBP-5 in mediating the anti-proliferation effect of tetrandrine in human colon cancer cells.
    Wu K; Zhou M; Wu QX; Yuan SX; Wang DX; Jin JL; Huang J; Yang JQ; Sun WJ; Wan LH; He BC
    Int J Oncol; 2015 Mar; 46(3):1205-13. PubMed ID: 25524807
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antitumor activity of 2-hydroxycinnamaldehyde for human colon cancer cells through suppression of β-catenin signaling.
    Lee MA; Park HJ; Chung HJ; Kim WK; Lee SK
    J Nat Prod; 2013 Jul; 76(7):1278-84. PubMed ID: 23855266
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Grape compounds suppress colon cancer stem cells in vitro and in a rodent model of colon carcinogenesis.
    Reddivari L; Charepalli V; Radhakrishnan S; Vadde R; Elias RJ; Lambert JD; Vanamala JK
    BMC Complement Altern Med; 2016 Aug; 16():278. PubMed ID: 27506388
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Wnt/β-catenin signaling mediates the antitumor activity of magnolol in colorectal cancer cells.
    Kang YJ; Park HJ; Chung HJ; Min HY; Park EJ; Lee MA; Shin Y; Lee SK
    Mol Pharmacol; 2012 Aug; 82(2):168-77. PubMed ID: 22550094
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ginsenoside Rg3 inhibits colorectal tumor growth through the down-regulation of Wnt/ß-catenin signaling.
    He BC; Gao JL; Luo X; Luo J; Shen J; Wang L; Zhou Q; Wang YT; Luu HH; Haydon RC; Wang CZ; Du W; Yuan CS; He TC; Zhang BQ
    Int J Oncol; 2011 Feb; 38(2):437-45. PubMed ID: 21152855
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PPARgamma is involved in mesalazine-mediated induction of apoptosis and inhibition of cell growth in colon cancer cells.
    Schwab M; Reynders V; Loitsch S; Shastri YM; Steinhilber D; Schröder O; Stein J
    Carcinogenesis; 2008 Jul; 29(7):1407-14. PubMed ID: 18544567
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pectolinarigenin inhibits non‑small cell lung cancer progression by regulating the PTEN/PI3K/AKT signaling pathway.
    Xu F; Gao X; Pan H
    Oncol Rep; 2018 Dec; 40(6):3458-3468. PubMed ID: 30542737
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiproliferation effect of evodiamine in human colon cancer cells is associated with IGF-1/HIF-1α downregulation.
    Huang J; Chen ZH; Ren CM; Wang DX; Yuan SX; Wu QX; Chen QZ; Zeng YH; Shao Y; Li Y; Wu K; Yu Y; Sun WJ; He BC
    Oncol Rep; 2015 Dec; 34(6):3203-11. PubMed ID: 26503233
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.